1. Home
  2. XBIT vs AIRS Comparison

XBIT vs AIRS Comparison

Compare XBIT & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.46

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$5.28

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
AIRS
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.2M
328.7M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
XBIT
AIRS
Price
$2.46
$5.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.4K
1.4M
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$151,818,000.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$5.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$1.51
52 Week High
$3.61
$12.00

Technical Indicators

Market Signals
Indicator
XBIT
AIRS
Relative Strength Index (RSI) 45.30 81.90
Support Level $2.15 $2.40
Resistance Level $2.49 $6.90
Average True Range (ATR) 0.06 0.44
MACD -0.01 0.12
Stochastic Oscillator 30.43 90.80

Price Performance

Historical Comparison
XBIT
AIRS

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: